BioSpace News Archive

Bolt Biotherapeutics, Inc. reported financial results for the first quarter ended March 31, 2022 and provided an update on recent business highlights.

Salarius Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, reported important corporate events and its financial results for the first quarter ended March 31, 2022.

Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic stem cell therapies, announced first quarter 2022 financial results and provided a corporate update.

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced its financial and operating results for the quarter ended March 31, 2022.

Rheos Medicines , a biopharmaceutical company bringing molecular targeting and precision treatment to autoimmune and inflammatory diseases, announced that Dania Rabah, PhD, the company’s Chief Scientific Officer, will deliver a keynote address today at the American Association for Pharmaceutical Scientists (AAPS) National Biotechnology Conference being held this week in Anaheim, CA.

Isomorphic Labs, a subsidiary of Alphabet, today announced the first phase of its management team.

Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its FlareHawk TiHawk™11 Interbody Fusion System.

NRx Pharmaceuticals, Inc., enrolled its first patient in one of two psychiatry studies being initiated this year; this first trial is studying patients with bipolar depression and sub-acute suicidality (not requiring hospitalization).

Longboard Pharmaceuticals, Inc. announced that members of its senior leadership team will participate in the Citi Movement Disorder & Epilepsy Co-Panel, on May 18, 2022, and present virtually in a fireside chat format at the H.C. Wainwright Global Investment Hybrid Conference, which is taking place May 23-26, 2022.

Accumulus Synergy, a nonprofit organization working to develop an information and data exchange platform aimed at transforming how drug innovators and health authorities worldwide interact, today announced AstraZeneca (LSE/STO/Nasdaq: AZN) has joined Accumulus Synergy as a sponsor company.